Polar Asset Management Partners’s ResMed RMD Stock Holding History

Polar Asset Management Partners’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$298K	Buy	+1,530	New	+$317K	﹤0.01%	544
2024 Q3	–	Sell	-5,200	Closed	-$995K	–	796
2024 Q2	$995K	Buy	+5,200	New	+$1.06M	0.02%	399
2023 Q1	–	Sell	-72,000	Closed	-$15M	–	1137
2022 Q4	$15M	Buy	72,000 +26,300	+58%	+$5.78M	0.18%	136
2022 Q3	$9.98M	Buy	45,700 +33,100	+263%	+$7.53M	0.12%	261
2022 Q2	$2.64M	Buy	+12,600	New	+$2.68M	0.03%	648

Other funds holding RMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Polar Asset Management Partners's RMD Position: Q2 2026 in Review

Polar Asset Management Partners opened a new position in ResMed (RMD) in Q2 2026: 1,530 shares worth $298K. The stake represents ﹤0.01% of the portfolio and ranks #544 among its holdings. This is a return to the name: Polar Asset Management Partners previously reported a position in RMD as recently as Q2 2024.

Polar Asset Management Partners first reported a position in RMD in Q2 2022 and has held it in 5 quarters since. The position peaked at $15M in Q4 2022. 889 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

Polar Asset Management Partners held 1,530 shares of ResMed worth $298K as of Q2 2026.
ResMed was a new Polar Asset Management Partners position in Q2 2026.
ResMed made up ﹤0.01% of Polar Asset Management Partners's portfolio in Q2 2026, its #544 holding.
Polar Asset Management Partners first reported a position in ResMed in Q2 2022 and has held it in 5 quarters since.
Polar Asset Management Partners's ResMed position peaked at $15M in Q4 2022.
889 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Polar Asset Management Partners's 13F filing for Q2 2026, filed 14 Aug 2026.